Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
topic_facet:"T4H8FMA7IM"
topic_facet:"Clinical Trial, Phase II"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22T4H8FMA7IM%22&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+II%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Siltuximab%22&type0%5B%5D=Subject&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22T4H8FMA7IM%22&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+II%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Siltuximab%22&type0%5B%5D=Subject&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22T4H8FMA7IM%22&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+II%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Siltuximab%22&type0%5B%5D=Subject&op0%5B%5D=OR
PubPharm (18)
1
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
enthalten in:
Blood advances
| 2022
von
van Rhee, F.
|
Rosenthal, A.
|
Kanhai, K.
| +4
Wird geladen...
2
Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab
enthalten in:
British journal of haematology
| 2021
von
van Rhee, F.
|
Rossi, J.
|
Simpson, D.
| +10
Wird geladen...
3
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease
enthalten in:
American journal of hematology
| 2020
von
Fajgenbaum, D.
|
Wu, D.
|
Goodman, A.
| +21
Wird geladen...
4
Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease : a prespecified, open-label, extension analysis of two trials
enthalten in:
The Lancet. Haematology
| 2020
von
van Rhee, F.
|
Casper, C.
|
Voorhees, P.
| +4
Wird geladen...
5
Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease : secondary analyses of phase II clinical trial data
enthalten in:
British journal of haematology
| 2019
von
Morra, D.
|
Pierson, S.
|
Shilling, D.
| +6
Wird geladen...
6
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma : an open-label phase I trial
enthalten in:
Blood cancer journal
| 2016
von
Shah, J.
|
Feng, L.
|
Thomas, S.
| +8
Wird geladen...
7
A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease
enthalten in:
Oncotarget
| 2015
von
van Rhee, F.
|
Casper, C.
|
Voorhees, P.
| +7
Wird geladen...
8
A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma
enthalten in:
American journal of hematology
| 2015
von
Orlowski, R.
|
Gercheva, L.
|
Williams, C.
| +17
Wird geladen...
9
A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome
enthalten in:
American journal of hematology
| 2014
von
Garcia-Manero, G.
|
Gartenberg, G.
|
Steensma, D.
| +7
Wird geladen...
10
Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma
enthalten in:
Blood
| 2014
von
San-Miguel, J.
|
Bladé, J.
|
Shpilberg, O.
| +18
ErratumIn: Blood. 2014 Aug 14;124(7):1201
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: T4H8FMA7IM
Filter aufheben
Thema: Clinical Trial, Phase II
Medienart
18
Aufsätze
18
E-Artikel
18
E-Ressourcen
Zeitschriftentitel
4
Clinical cancer research : an official journal ...
3
American journal of hematology
3
British journal of haematology
1
Blood
1
Blood advances
1
Blood cancer journal
1
British journal of cancer
1
European journal of cancer (Oxford, England : 1...
1
Oncotarget
1
The Lancet. Haematology
1
The New England journal of medicine
Alle anzeigen ...
weniger ...
Thema
18
Antibodies, Monoclonal
Clinical Trial, Phase II
T4H8FMA7IM
18
siltuximab
17
Journal Article
12
Interleukin-6
12
Randomized Controlled Trial
11
Research Support, Non-U.S. Gov't
9
Multicenter Study
7
Antineoplastic Agents
7
Clinical Trial, Phase I
5
IL6 protein, human
4
69G8BD63PP
4
Bortezomib
3
9007-41-4
3
Boronic Acids
3
C-Reactive Protein
3
Pyrazines
3
Research Support, N.I.H., Extramural
2
7S5I7G3JQL
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2020-
14
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
18
Englisch
Haven't found what you're looking for?
Wird geladen...